期刊文献+

头颈鳞癌切缘突变型p53表达与肿瘤局部复发和预后的关系 被引量:2

The Relationship between P53 Protein Expression, Prognosis and Local Tumor Recurrence in the Surgical Margins of Patients with Head and Neck Squamous Cell Carcinoma
下载PDF
导出
摘要 目的:探讨头颈鳞癌手术切缘p53表达及其与肿瘤局部复发和预后的关系。方法:用免疫组织化学的方法检测82例头颈鳞癌患者手术切缘中p53的表达情况,并分析其与肿瘤局部复发,临床病理学参数和预后之间的关系。结果:在82例头颈鳞癌患者中,切缘塞变型p53阳性表达率为59.76%(49/82)。阳性表达主要定位于切缘上皮细胞核。p53蛋白在头颈鳞癌手术切缘中的表达显著高于其在正常口腔粘膜组织中的表达(x2=10.497,P<0.05)。头颈鳞癌患者手术切缘p53的表达与肿瘤分化程度(x2:12.332,P<0.01)和局部复发显著相关(x2=5.425,P<0.05),但与患者年龄、性别、肿瘤病理分期以及淋巴结转移无关(P>0.05)。切缘p53表达阴性组较阳性组术后可能有较好的预后(x2=3.559,P=0.059)。结论:切缘p53的阳性表达与头颈鳞癌术后肿瘤的进展有关,它有望成为指导头颈鳞癌治疗和判断预后的一项重要指标。 Objective: To investigate the expression of P53 protein in the surgical margins of patients with head and neck squamous cell carcinoma (HNSCC), and to analyze its relationship with local tumor recurrence and prognosis. Methods: The expression of P53 protein in 82 cases with HNSCC was detected by immunohistochemistry. The correlations among P53 protein, local recurrence, clinicopathologic parameters and prognosis in these cases were investigated. Results: Of the 82 cases with HNSCC, 59.76% (49/82) cases had positive expression of P53 protein in the surgical margins. P53 protein was mainly detected in the nucleus of epithelial cells in the surgical margins. The expression of P53 protein was significantly higher in the surgical margins of patients with HNSCC than in normal oral mucosa (χ^2=10.497, P〈0.05). Positive expression of P53 protein was significantly correlated with tumor differentiation (χ^2=12.332, P〈0.01) and local recurrence (χ^2= 5.425, P〈0.05). No correlations were found among P53 expression and age, gender, pathological stage, or lymph node metastasis (P〉0.05). The prognosis may be better in patients with positive p53 protein than in patients without P53 expression (χ^2=3.559, P=0.059). Conclusion: The expression of P53 protein in surgical margins is correlated with the development of HNSCC after surgery. P53 protein expression may serve as a prognostic factor and can help make informed judgments about which patients will benefit from treatment.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2009年第14期816-819,共4页 Chinese Journal of Clinical Oncology
基金 四川省卫生厅科研基金资助(编号:070030)
关键词 头颈鳞状细胞癌 p53 切缘组织 局部复发 预后 Head and neck squamous cell carcinoma p53 Margin Local recurrence Prognosis
  • 相关文献

参考文献12

  • 1李超,陈建超,王朝晖,孙维刚,王影.头颈部鳞癌安全手术切缘的评价[J].中华口腔医学杂志,2006,41(8):478-480. 被引量:13
  • 2李超,冯红超,宋宇峰.口腔鳞癌中Angiopoietin-2的表达与肿瘤血管生成及成熟的关系研究[J].中国肿瘤临床,2005,32(13):729-734. 被引量:7
  • 3Poeta LM,,Goldwasser M A,Forastiere A,et al.Prognostic implication of p53 mutations in HNSCC: Results of Intragroup margin study (E4393)[].ASCO Meeting Abstracts.2006 被引量:1
  • 4Metges J,Volant A,Auperin A, et al.No statistical impact of intra-tumoral overexpression of EGFR, VEGF and p53 on the overall survival in head and neck squamous cell cancer (HNSCC): Preliminary results of the GORTEC 99-02 randomized trial[].ASCO Meeting Abstracts.2007 被引量:1
  • 5Metges J,Guenet D,Auperin A, et al.Analysis of EGFr, VEGF and p53 in serum of head and neck squamous cell cancer (HN-SCC) : Preliminary results of the GORTEC 99-02 randomized triai[].ASCO Meeting Abstracts.2006 被引量:1
  • 6T Soussi,B Asselain,D Hamroun,S Kato,C Ishioka,M Claustres,C Béroud.Meta-analysis of the p53 mutation database for mutant p53 biological activity reveals a methodologic bias in mutation detection[].Clinical Cancer Research.2006 被引量:1
  • 7Kawamata H,Omotehara F,Nakashiro K,et al.Oncogenic mutation of thep53gene derived from head and neck cancer prevents cells from un-dergoing apoptosis after DNA damage[].International Journal of Oncology.2007 被引量:1
  • 8BrennanJA,BoyleJO,KochWM,etal.Associationbetweencigaretesmokingandmutationofthep53geneinsquamouscelcarcinomaoftheheadandneck[].The New England Journal of Medicine.1995 被引量:1
  • 9Tunca B,,Erisen L,Coskun H,et al.p53 gene mutations in sur-gical margins and primary tumor tissues of patients with squamouscell carcinoma of the head and neck[].TUMORI.2007 被引量:1
  • 10van,Houten,VM,Leemans,CR,Kummer,JA.Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study[].Clinical Cancer Research.2004 被引量:1

二级参考文献33

  • 1Alcalde RE, Terakado N, Otsuki K, et al. Angiogenesis and expression of platelet-derived endothelial cell growth factor in oral squamous cell carcinoma [J]. Oncology, 1997, 54(4):324~ 328 被引量:1
  • 2Lopez-Graniel CM, Tamez de Leon D, Meneses-Garcia A, et al.Tumor angiogenesis as a prognostic factor in oral cavity carcinomas[J]. Exp Clin Cancer Res, 2001, 20(4):463~468 被引量:1
  • 3Risau W. Mechanisms of angiogenesis [J]. Nature, 1997, 386(6626):671-674 被引量:1
  • 4Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation [J]. Nature, 2000, 407(6801) :242 ~248 被引量:1
  • 5Loughna S, Sato TN. Angiopoietin and Tie signaling pathways in vascular development [J]. Matrix Biol, 2001, 20(5~6):319~325 被引量:1
  • 6Lauren J, Gunji Y, Alitalo K. Is angiopoietin-2 necessary for the initiation of tumor angiogenesis [J]? AmJ Pathol, 1998, 153(5):1333~1339 被引量:1
  • 7Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis [J]. Science, 1997, 277(5322):55~60 被引量:1
  • 8Holash J, Wiegand SJ, Yancopoulos GD. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF [J]. Oncogene,1999, 18(38):5356~5362 被引量:1
  • 9Shepro D, Morel NML. Pericyte physiology [J]. FASEBJ, 1993, 7(11):1031-1038 被引量:1
  • 10Eberhard A, Kahlert S, Goede V. Heterogeneity of Angiogenesis and Blood Vessel Maturation in Human Tumors: Implications for Antiangiogenic Tumor Therapies [J]. Cancer Res, 2000, 60(5):1388~1393 被引量:1

共引文献18

同被引文献10

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部